Why Jason Begley Built Zennetix
Updated: 6 days ago
Jason Begley didn't get into tissue culture because he thought cannabis needed another clone company. After years working in the cannabis industry and consulting with cultivators, he kept seeing the same problem: growers and breeders could spend years developing and maintaining valuable genetics, only to have viruses and viroids move through their plant stock.
That problem led Jason to tissue culture.
He thought the solution would come relatively quickly.
Get the lab running
Develop the protocols
Start producing clean plants.
It didn't work that way.
Cannabis turned out to be particularly difficult in tissue culture. Different cultivars responded differently. Media and protocols had to be developed and adjusted. Contamination could destroy a run. Plants that performed well in culture didn't necessarily perform equally well during acclimation. And processes that worked at small scale didn't always translate cleanly to commercial production.
Building Zennetix ultimately took more than three years of development and more than $1 million invested in R&D, consultants, failed runs, protocol development, and learning what actually works at commercial scale.
From Clean Plants to Genetic Preservation jason Zennetix
The original problem was plant health, but Jason's vision for Zennetix grew as the company developed. If tissue culture could be used to clean and propagate cannabis genetics, it could also provide a way to protect them. Cultivators and breeders traditionally maintain important cultivars as living mother plants. But mother rooms aren't permanent archives. Pathogens, facility problems, regulatory disruptions, fires, equipment failures, or simply losing a plant can mean losing a genotype entirely.
That led to the idea to build a system for preserving important cannabis genetics outside of active production, with documented provenance, pathogen screening, and genetic characterization.
Building a Network Around Cannabis Genetics
Jason also saw an opportunity to connect some of the industry's best independent cultivators without asking them to give up control of the genetics they spent years developing.
The Zennetix Shared Genetic Network is being built around that idea.
The Network is being built around a select group of small scale craft operators, with one founding operator per state. Members can preserve their own genetics while choosing which cultivars, if any, they want to make available to other approved members of the Network.
Genetics entering the Network go through pathogen screening, tissue culture, DNA fingerprinting, and documentation before being vaulted. The original operator retains ownership, while Zennetix serves as the neutral custodian responsible for preservation, verification, and plant fulfillment.
The idea is to give craft operators access to clean, verified genetics from other respected cultivators while creating a system that protects provenance, ownership, and the genetics themselves.
Preserving Genetics for Research
Jason has a long-term vision that goes beyond commercial cultivation.
Cannabis research has historically faced a fundamental problem in that researchers cannot build reproducible science if the biological material itself isn't reproducible. As medical and pharmaceutical research involving cannabis expands, researchers will need access to plant material with known identity, provenance, health status, and genetic background.
One of Jason's goals is therefore to identify and preserve cultivars that have already been associated with therapeutic or medical research, including genetics studied in neurological disease, cancer, and other areas.
Rather than allowing potentially important genetics to disappear, change hands without documentation, or exist only as an unverified cultivar name, Zennetix can preserve the actual plant genotype and build a record around it.
Over time, that could create a library of clean, verified cannabis genetics that researchers, universities, and pharmaceutical developers can return to when they need consistent biological starting material.
The Bigger Vision for
Zennetix
What started as an effort to solve a pathogen problem has become something much larger.
Jason envisions Zennetix as an infrastructure around cannabis genetics: cleaning them, preserving them, verifying their identity, documenting their history, connecting cultivators through them, and protecting genetics that may someday become important to medical research.
Tissue culture is the technology that made that possible.
The bigger idea is making sure valuable cannabis genetics don't disappear, and that the genetics the industry relies on today remain available, identifiable, and useful for whatever comes next.
Subscribe to our newsletter for the latest updates on Zennetix's innovations and the future of plant tissue culture.
Comments